VEGF, VEGFR2 and GSTM1 polymorphisms in outcome of multiple myeloma patients treated with thalidomide-based regimens

Detalles Bibliográficos
Autores principales: Lopes-Aguiar, L, Delamain, M T, Brito, A B C, Lourenço, G J, Costa, E F D, Oliveira, G B, Vassallo, J, De Souza, C A, Lima, C S P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520405/
https://www.ncbi.nlm.nih.gov/pubmed/28665417
http://dx.doi.org/10.1038/bcj.2017.58

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520405/
https://www.ncbi.nlm.nih.gov/pubmed/28665417
http://dx.doi.org/10.1038/bcj.2017.58

Ejemplares similares